Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodiesNature communications, 2023-02, Vol.14 (1), p.824-824, Article 824 [Peer Reviewed Journal]2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-36561-6 ;PMID: 36788246Full text available |
|
2 |
Material Type: Article
|
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfectionEBioMedicine, 2021-09, Vol.71, p.103561-103561, Article 103561 [Peer Reviewed Journal]2021 The Author(s) ;Attribution - NonCommercial - NoDerivatives ;2021 The Author(s) 2021 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2021.103561 ;PMID: 34455390Full text available |
|
3 |
Material Type: Article
|
Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2PLoS computational biology, 2023-08, Vol.19 (8), p.e1011282-e1011282 [Peer Reviewed Journal]Copyright: © 2023 Clairon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Clairon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;2023 Clairon et al 2023 Clairon et al ;ISSN: 1553-7358 ;ISSN: 1553-734X ;EISSN: 1553-7358 ;DOI: 10.1371/journal.pcbi.1011282 ;PMID: 37549192Full text available |
|
4 |
Material Type: Article
|
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionNature communications, 2024-03, Vol.15 (1), p.2254-2254 [Peer Reviewed Journal]2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2024 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-024-46490-7 ;PMID: 38480689Full text available |
|
5 |
Material Type: Article
|
Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 VaccineFrontiers in immunology, 2022-02, Vol.13, p.790212 [Peer Reviewed Journal]Copyright © 2022 Gallais, Gantner, Planas, Solis, Bruel, Pierre, Soulier, Rossolillo, Fourati, Sibilia, Schwartz and Fafi-Kremer. ;Attribution ;Copyright © 2022 Gallais, Gantner, Planas, Solis, Bruel, Pierre, Soulier, Rossolillo, Fourati, Sibilia, Schwartz and Fafi-Kremer 2022 Gallais, Gantner, Planas, Solis, Bruel, Pierre, Soulier, Rossolillo, Fourati, Sibilia, Schwartz and Fafi-Kremer ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2022.790212 ;PMID: 35281046Full text available |
|
6 |
Material Type: Article
|
Divergent adaptive immune responses define two types of long COVIDFrontiers in immunology, 2023-07, Vol.14, p.1221961-1221961 [Peer Reviewed Journal]Copyright © 2023 Kervevan, Staropoli, Slama, Jeger-Madiot, Donnadieu, Planas, Pietri, Loghmari-Bouchneb, Alaba Tanah, Robinot, Boufassa, White, Salmon-Ceron and Chakrabarti. ;Attribution ;Copyright © 2023 Kervevan, Staropoli, Slama, Jeger-Madiot, Donnadieu, Planas, Pietri, Loghmari-Bouchneb, Alaba Tanah, Robinot, Boufassa, White, Salmon-Ceron and Chakrabarti 2023 Kervevan, Staropoli, Slama, Jeger-Madiot, Donnadieu, Planas, Pietri, Loghmari-Bouchneb, Alaba Tanah, Robinot, Boufassa, White, Salmon-Ceron and Chakrabarti ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2023.1221961 ;PMID: 37559726Full text available |
|
7 |
Material Type: Article
|
Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and VaccinationViruses, 2022-07, Vol.14 (7), p.1491 [Peer Reviewed Journal]COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;2022 by the authors. 2022 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v14071491 ;PMID: 35891471Full text available |
|
8 |
Material Type: Article
|
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective studyEBioMedicine, 2021-11, Vol.73, p.103637-103637, Article 103637 [Peer Reviewed Journal]2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2021 The Authors 2021 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2021.103637 ;PMID: 34678613Full text available |
|
9 |
Material Type: Article
|
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort studyEClinicalMedicine, 2022-09, Vol.51, p.101576-101576, Article 101576 [Peer Reviewed Journal]2022 The Authors ;Attribution - NonCommercial - NoDerivatives ;2022 The Authors 2022 ;ISSN: 2589-5370 ;EISSN: 2589-5370 ;DOI: 10.1016/j.eclinm.2022.101576 ;PMID: 35891947Full text available |
|
10 |
Material Type: Article
|
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2EBioMedicine, 2022-03, Vol.77, p.103934-103934, Article 103934 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2022 The Author(s) 2022 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2022.103934 ;PMID: 35290827Full text available |
|
11 |
Material Type: Article
|
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populationsScience Translational Medicine, 2020-09, Vol.12 (559) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 1946-6234 ;EISSN: 1946-6242 ;DOI: 10.1126/scitranslmed.abc3103 ;PMID: 32817357Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Modeling the evolution of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2PLoS computational biology, 2023-07 [Peer Reviewed Journal]Attribution ;ISSN: 1553-734X ;EISSN: 1553-7358Full text available |
|
13 |
Material Type: Article
|
Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat CellsJournal of virology, 2022-07, Vol.96 (14), p.e0060822-e0060822 [Peer Reviewed Journal]Copyright © 2022 American Society for Microbiology. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2022 American Society for Microbiology. 2022 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.00608-22 ;PMID: 35862713Full text available |
|
14 |
Material Type: Article
|
Severe relapse of SARS‐CoV‐2 infection in a kidney transplant recipient with negative nasopharyngeal SARS‐CoV‐2 RT‐PCR after rituximabAmerican journal of transplantation, 2022-08, Vol.22 (8), p.2099-2103 [Peer Reviewed Journal]2022 The American Society of Transplantation and the American Society of Transplant Surgeons. ;2022 The American Society of Transplantation and the American Society of Transplant Surgeons ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.17000 ;PMID: 35150193Full text available |
|
15 |
Material Type: Article
|
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibodyProceedings of the National Academy of Sciences - PNAS, 2022-05, Vol.119 (20), p.e2120976119-e2120976119 [Peer Reviewed Journal]Copyright National Academy of Sciences May 17, 2022 ;Attribution ;Copyright © 2022 the Author(s). Published by PNAS. 2022 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2120976119 ;PMID: 35549549Full text available |
|
16 |
Material Type: Article
|
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myelomaBlood, 2022-02, Vol.139 (6), p.942-946 [Peer Reviewed Journal]2022 American Society of Hematology ;Copyright ;Copyright © 2022 American Society of Hematology. All rights reserved. 2022 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021013714 ;PMID: 34905598Full text available |
|
17 |
Material Type: Article
|
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1Journal of virology, 2024-01 [Peer Reviewed Journal]Copyright ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.01351-23 ;PMID: 38088562Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since InfectionThe Journal of infectious diseases, 2021-11, Vol.224 (9), p.1489-1499 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiab375 ;PMID: 34282461Full text available |
|
19 |
Material Type: Article
|
Neutralizing antibody levels as a correlate of protection against SARS‐CoV‐2 infection: a modeling analysisClinical pharmacology and therapeutics, 2024-01 [Peer Reviewed Journal]Attribution - NonCommercial ;ISSN: 0009-9236 ;EISSN: 1532-6535 ;DOI: 10.1002/cpt.3069 ;PMID: 37795693Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodiesCell reports. Medicine, 2022-12, Vol.3 (12), p.100850-100850, Article 100850 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2022 The Author(s) 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100850 ;PMID: 36450283Full text available |